检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Iberdomide, bortezomib, and dexamethasone (IberVd) in transplant-ineligible newly diagnosed multiple myeloma (NDMM): results from the CC-220-MM-001 trial

Darrell White,Brea Lipe,Mercedes Gironella Mesa,Ruben Niesvizky,Albert Oriol,Anna Sureda Balari,Manisha Bhutani,Cristina Encinas,Abdullah Khan,Michael Amatangelo,Kexin Jin,Thomas Solomon,Kevin Hong,Alpesh Amin,Paulo Maciag,Niels van de Donk,Sagar Lonial

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览13
暂无评分
关键词
multiple myeloma,bortezomib,transplant-ineligible
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要